NEW YORK () -- The top-five holdings in the iShares Nasdaq Biotechnology ETF () represent some 42% of the exchange-traded fund. These are Celgene () , Amgen () , Gilead () , Regeneron () and holding Biogen () .
All five of these stocks show a similar technical setup that points to an upside move in the IBB...